Skip to main content
SpringerLink
Log in

Serum hepatitis B virus DNA as a predictor of the development of cirrhosis and hepatocellular carcinoma

  • Published:
Current Hepatitis Reports Aims and scope Submit manuscript

Abstract

Chronic hepatitis B frequently progresses to cirrhosis and hepatocellular carcinoma. An elevated serum level of hepatitis B virus DNA is a major risk factor for cirrhosis and hepatocellular carcinoma, and there is a dose-response relationship between the serum hepatitis B virus DNA level and the risk of these complications. To lower the viral load to its lowest level is the method of choice to prevent major liver complications in chronic hepatitis B.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Goldstein ST, Zhou F, Hadler SC, et al.:A mathematical model to estimate global hepatitis B disease burden and vaccination impact.Int J Epidemiol 2005,34:1329–1339.

    Article  PubMed  Google Scholar 

  2. Chen CJ, Wang LY, Yu MW:Epidemiology of hepatitis B virus infection in the Asia-Pacific region.J Gastroenterol Hepatol 2000,15(suppl):E3-E6.

    Article  PubMed  Google Scholar 

  3. Beasley RP:Hepatitis B virus. The major etiology of hepatocellular carcinoma.Cancer 1988,61:1942–1956.

    Article  PubMed  CAS  Google Scholar 

  4. Lok AS, McMahon BJ:Chronic hepatitis B.Hepatology 2001,34:1225–1241.

    Article  PubMed  CAS  Google Scholar 

  5. Perz JF, Armstrong GL, Farrington LA, et al.:The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.J Hepatol 2006,45:529–538.

    Article  PubMed  Google Scholar 

  6. Beasley RP, Trepo C, Stevens CE, Szmuness W:The e antigen and vertical transmission of hepatitis B surface antigen.Am J Epidemiol 1977,105:94–98.

    PubMed  CAS  Google Scholar 

  7. McMahon BJ, Alward WL, Hall DB, et al.:Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state.J Infect Dis 1985,151:599–603.

    PubMed  CAS  Google Scholar 

  8. Chen DS:From hepatitis to hepatoma: lessons from type B viral hepatitis.Science 1993,262:369–370.

    Article  PubMed  CAS  Google Scholar 

  9. Chu CM, Liaw YF:Natural history of chronic hepatitis B virus infection: an immunopathological study.J Gastroenterol Hepatol 1997,12:S218-S222.

    Article  PubMed  CAS  Google Scholar 

  10. Fattovich G, Brollo L, Giustina G, et al.:Natural history and prognostic factors for chronic hepatitis type B.Gut 1991,32:294–298.

    Article  PubMed  CAS  Google Scholar 

  11. Hsu YS, Chien RN, Yeh CT, et al.:Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.Hepatology 2002,35:1522–1527.

    Article  PubMed  Google Scholar 

  12. Huo T, Wu JC, Hwang SJ, et al.:Factors predictive of liver cirrhosis in patients with chronic hepatitis B: a multivariate analysis in a longitudinal study.Eur J Gastroenterol Hepatol 2000,12:687–693.

    Article  PubMed  CAS  Google Scholar 

  13. Liaw YF, Tai DI, Chu CM, Chen TJ:The development of cirrhosis in patients with chronic type B hepatitis: a prospective study.Hepatology 1988,8:493–496.

    Article  PubMed  CAS  Google Scholar 

  14. Lin SM, Sheen IS, Chien RN, et al.:Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection.Hepatology 1999,29:971–975.

    Article  PubMed  CAS  Google Scholar 

  15. Yu MW, Hsu FC, Sheen IS, et al.:Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers.Am J Epidemiol 1997,145:1039–1047.

    PubMed  CAS  Google Scholar 

  16. Fattovich G, Pantalena M, Zagni I, et al.:Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.Am J Gastroenterol 2002,97:2886–2895.

    Article  PubMed  Google Scholar 

  17. de Jongh FE, Janssen HL, de Man RA, et al.:Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver.Gastroenterology 1992,103:1630–1635.

    PubMed  Google Scholar 

  18. Chen CJ, Yu MW, Liaw YF:Epidemiological characteristics and risk factors of hepatocellular carcinoma.J Gastroenterol Hepatol 1997,12:S294-S308.

    Article  PubMed  CAS  Google Scholar 

  19. Beasley RP:Hepatitis B virus as the etiological agent in hepatocellular carcinoma: epidemiological consideration.Hepatology 1982,2:21–26.

    Google Scholar 

  20. Chen CJ, Yang HI, Su J, et al.:Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.JAMA 2006,295:65–73.

    Article  PubMed  CAS  Google Scholar 

  21. Iloeje UH, Yang HI, Su J, et al.:Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.Gastroenterology 2006,130:678–686.

    Article  PubMed  Google Scholar 

  22. Yu MW, Yeh SH, Chen PJ, et al.:Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.J Natl Cancer Inst 2005,97:265–272.

    Article  PubMed  CAS  Google Scholar 

  23. You SL, Yang HI, Chen CJ:Seropositivity of hepatitis B e antigen and hepatocellular carcinoma.Ann Med 2004,36:215–224.

    Article  PubMed  CAS  Google Scholar 

  24. Niederau C, Heintges T, Lange S, et al.:Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.N Engl J Med 1996,334:1422–1427.

    Article  PubMed  CAS  Google Scholar 

  25. Fattovich G, Giustina G, Schalm SW, et al.:Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis.Hepatology 1995,21:77–82.

    PubMed  CAS  Google Scholar 

  26. McMahon BJ, Holck P, Bulkow L, Snowball M:Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.Ann Intern Med 2001,135:759–768.

    PubMed  CAS  Google Scholar 

  27. Yang HI, Lu SN, Liaw YF, et al.:Hepatitis B e antigen and the risk of hepatocellular carcinoma.N Engl J Med 2002,347:168–174.

    Article  PubMed  CAS  Google Scholar 

  28. Chen CJ, Yang HI, You SL:Hepatitis B e antigen and the risk of hepatocellular carcinoma [author reply].N Engl J Med 2002,347:1722.

    Article  Google Scholar 

  29. Yuan HJ, Yuen MF, Ka-Ho Wong D, et al.:The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B.J Viral Hepat 2005,12:373–379.

    Article  PubMed  Google Scholar 

  30. Chen G, Lin W, Shen F, et al.:Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study.Am J Gastroenterol 2006,101:1797–1803.

    Article  PubMed  Google Scholar 

  31. Ikeda K, Arase Y, Kobayashi M, et al.:Consistently low hepatitis B virus DNA saves patients from hepatocellular carcinogenesis in HBV-related cirrhosis. A nested case-control study using 96 untreated patients.Intervirology 2003,46:96–104.

    Article  PubMed  CAS  Google Scholar 

  32. Tang B, Kruger WD, Chen G, et al.:Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers.J Med Virol 2004,72:35–40.

    Article  PubMed  CAS  Google Scholar 

  33. Liu CJ, Chen BF, Chen PJ, et al.:Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.J Infect Dis 2006,193:1258–1265.

    Article  PubMed  CAS  Google Scholar 

  34. Ohata K, Hamasaki K, Toriyama K, et al.:High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.J Gastroenterol Hepatol 2004,19:670–675.

    Article  PubMed  Google Scholar 

  35. Mahmood S, Niiyama G, Kamei A, et al.:Influence of viral load and genotype in the progression of hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.Liver Int 2005,25:220–225.

    Article  PubMed  Google Scholar 

  36. Ikeda K, Arase Y, Kobayashi M, et al.:Hepatitis B virus-related hepatocellular carcinogenesis and its prevention.Intervirology 2005,48:29–38.

    Article  PubMed  CAS  Google Scholar 

  37. Chien YC, Jan CF, Kuo HS, Chen CJ:Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.Epidemiol Rev 2006,28:126–135.

    Article  PubMed  Google Scholar 

  38. Centers for Disease Control and Prevention (CDC):Global progress towards universal childhood hepatitis B vaccination.MMWR 2003,52:868–870.

    Google Scholar 

  39. Merican I, Guan R, Amarapuka D, et al.:Chronic hepatitis B virus infection in Asian countries.J Gastroenterol Hepatol 2000,15:1356–1361.

    Article  PubMed  CAS  Google Scholar 

  40. Da Silva LC, Madruga CL, Carrilho FJ, et al.:Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection.J Gastroenterol 1996,31:696–701.

    Article  PubMed  Google Scholar 

  41. Liaw YF, Sheen IS, Chen TJ, et al.:Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study.Hepatology 1991,13:627–631.

    Article  PubMed  CAS  Google Scholar 

  42. Sampliner RE, Hamilton FA, Iseri OA, et al.:The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers.Am J Med Sci 1979,277:17–22.

    Article  PubMed  CAS  Google Scholar 

  43. Wu TT, Hsu HC, Chen DS, et al.:Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma.J Hepatol 1987,4:45–51.

    Article  PubMed  CAS  Google Scholar 

  44. de Franchis R, Hadengue A, Lau G, et al.:EASL International Consensus Conference on Hepatitis B. 13–14 September, 2002 Geneva, Switzerland. Consensus statement (long version).J Hepatol 2003,39(suppl 1):S3-S25.

    PubMed  Google Scholar 

  45. Liaw YF, Leung N, Guan R, et al.:Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update.Liver Int 2005,25:472–489.

    Article  PubMed  Google Scholar 

  46. Lok AS, McMahon BJ:Chronic hepatitis B: update of recommendations.Hepatology 2004,39:857–861.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Genomics Research Center, Academia Sinica, 128 Academia Road Section 2, 115, Nankang, Taipei, Taiwan

    Chien-Jen Chen ScD, Uchenna H. Iloeje MD & Hwai-I Yang PhD

Authors
  1. Chien-Jen Chen ScD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Uchenna H. Iloeje MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hwai-I Yang PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chien-Jen Chen ScD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, CJ., Iloeje, U.H. & Yang, HI. Serum hepatitis B virus DNA as a predictor of the development of cirrhosis and hepatocellular carcinoma. Current Hepatitis Reports 6, 9–16 (2007). https://doi.org/10.1007/BF02942173

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02942173

Keywords

Search

Navigation